Merck to acquire life science company Mirus Bio for US$ 600 million

Acquisition will advance Merck’s integrated offering for viral vector manufacturing

Suven Life Sciences posts Q4 FY24 consolidated loss at Rs. 26.54 Cr

The company has posted net loss of Rs. 105.07 crores for the Financial Year ended March 31, 2024

RPG Life Sciences posts Q4 FY24 PAT at Rs. 13.24 Cr

The company has posted net profit of Rs.87.66 crores for the Financial Year ended March 31, 2024

Suven Life Sciences to present phase-2 results on Samelisant at AAN 2024

Global Phase-3 study initiation expected in the second half of 2024

Merck India appoints Dhananjay Singh as MD Merck Life Science in India

Asahi Songwon Colors acquires remaining 22% stake in Atlas Life Sciences

Asahi Songwon Colors' shareholding in ALSPL has increased from 78% to 100%

Merck invests € 300 million in new Life Science production site in South Korea

New Bioprocessing Production Center in Daejeon to supply products to customers in Asia-Pacific for development and production of biologics

Nirma acquires majority stake in Glenmark Life Sciences

Completes acquisition of 75% of share capital from Glenmark Pharmaceuticals

RPG Life Sciences posts Q3 FY24 PAT at Rs. 26.46 Cr

RPG Life Sciences Limited has reported total income of Rs. 155.62 crores during the period ended December 31, 2023

Glenmark Life Sciences posts Q3 FY24 PAT at Rs. 118.76 Cr

Glenmark Life Sciences has reported total income of Rs. 574.49 crores during the period ended December 31, 2023